Critical Care

official impact factor 4.60

This article is part of the supplement: Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma

Highly Access Email this article to a friend

Optimizing the use of blood products in trauma care

John R Hess* and Seppo Hiippala

Critical Care 2005, 9(Suppl 5):S10-S14 doi:10.1186/cc3780

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.